Literature DB >> 16509241

Surgical management of intracranial complications of otogenic infection.

Ricardo Bento1, Rubens de Brito, Guilherme Carvalhal Ribas.   

Abstract

We conducted a prospective study of 24 patients to evaluate the evolution of intracranial complications resulting from otogenic infection and to correlate the course of the disease with surgical treatment. Almost half of the patients were younger than 18 years, and most were male. The most common intracranial complication was brain abscess, followed by meningitis, lateral sinus thrombosis, and extradural abscess. Cholesteatoma was found in 14 patients. After the complications were confirmed by computed tomography, initial treatment consisted of intravenous systemic antibiotics followed by mastoid surgery. The surgical approach was determined by the type of ear disease, not by the type of neurologic complication. Modified radical mastoidectomy was performed in 16 patients, tympanomastoidectomy in 6, and myringotomy in 2. No significant morbidity, mortality, recurrence, or residual neurologic deficit was observed at the 6-month follow-up. Early surgical intervention is important in achieving positive outcomes in patients with such intracranial complications.

Entities:  

Mesh:

Year:  2006        PMID: 16509241

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  3 in total

1.  To Study the Prevelance of Extracranial & Intracranial Complications in Chronic Suppurative Otitis Media.

Authors:  Priyanka Verma; Aditya Gargava; Smiriti Saxena; V P Narvey
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-02-11

2.  Complications of chronic otitis media with cholesteatoma during a 10-year period in Kosovo.

Authors:  A Mustafa; A Heta; B Kastrati; Sh Dreshaj
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-14       Impact factor: 2.503

3.  Bony wall damage in the region of the middle and posterior cranial fossa observed during otosurgery.

Authors:  Maciej Wiatr; Jacek Składzień; Jerzy Tomik; Paweł Stręk; Anna Przeklasa-Muszyńska
Journal:  Med Sci Monit       Date:  2012-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.